JP Morgan Maintains Overweight on Elevance Health, Raises Price Target to $631
Elevance Health, Inc -0.57%
Elevance Health, Inc ELV | 419.84 | -0.57% |
JP Morgan analyst Lisa Gill maintains Elevance Health (NYSE:
ELV) with a Overweight and raises the price target from $628 to $631.